ST Germain D J Co. Inc. Has $34.69 Million Stock Holdings in The Procter & Gamble Company (NYSE:PG)

ST Germain D J Co. Inc. grew its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 6.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 206,896 shares of the company’s stock after buying an additional 11,730 shares during the quarter. Procter & Gamble accounts for about 1.6% of ST Germain D J Co. Inc.’s holdings, making the stock its 11th biggest position. ST Germain D J Co. Inc.’s holdings in Procter & Gamble were worth $34,686,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Itau Unibanco Holding S.A. bought a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $28,000. Fairway Wealth LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $29,000. RPg Family Wealth Advisory LLC bought a new stake in shares of Procter & Gamble in the third quarter valued at $33,000. Quest Partners LLC bought a new position in shares of Procter & Gamble during the 2nd quarter worth $36,000. Finally, Fairfield Financial Advisors LTD purchased a new stake in Procter & Gamble in the 2nd quarter worth about $44,000. Institutional investors own 65.77% of the company’s stock.

Insiders Place Their Bets

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the sale, the insider now directly owns 11,595 shares in the company, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 75,439 shares of company stock worth $13,317,460. Company insiders own 0.18% of the company’s stock.

Procter & Gamble Stock Performance

NYSE:PG traded down $2.91 during trading hours on Friday, reaching $159.19. The company had a trading volume of 2,531,893 shares, compared to its average volume of 5,868,981. The firm’s 50 day moving average price is $169.77 and its 200-day moving average price is $169.64. The firm has a market cap of $374.90 billion, a price-to-earnings ratio of 27.45, a PEG ratio of 3.70 and a beta of 0.45. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the prior year, the business earned $1.83 EPS. The business’s quarterly revenue was down .6% on a year-over-year basis. On average, analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current year.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of research analyst reports. Wells Fargo & Company dropped their price target on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research report on Tuesday. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Morgan Stanley increased their price objective on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Evercore ISI increased their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $179.75.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.